Please assess the completion status of the following clinical trial:

Trial Title: A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any infant scheduled for unilateral or bilateral inguinal hernia repair (with or without circumcision)~* Any infant whose gestational age is 26 weeks or more (GA = 182 days)~* Any infant whose post-menstrual age is up to 60 weeks (PMA = 426 days)~Exclusion Criteria:~* Any child older than 60 weeks post-menstrual age~* Any child born less than 26 weeks gestation~* Any contraindication to general or spinal/caudal anesthesia (for example: neuromuscular disorder or coagulopathy)~* Pre-operative ventilation immediately prior to surgery~* Congenital heart disease that has required ongoing pharmacotherapy~* Known chromosomal abnormality or any other known acquired or congenital abnormalities (apart from prematurity) which are likely to affect development~* Children where follow-up would be difficult for geographic or social reasons~* Families where English is not the primary language spoken at home~* Known neurological injury such as cystic periventricular leukomalacia (PVL), or grade 3 or 4 intra ventricular hemorrhage (ICH) (+/- post hemorrhage ventricular dilation)~* Previous exposure to volatile anesthesia or benzodiazepines as a neonate or in the third trimester in utero.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 60 Weeks
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Regional Anesthesia
- 2 (Type: ACTIVE_COMPARATOR): General Anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).